114 results
Page 4 of 6
8-K
EX-99.1
w70y0oaqifx4vr5s2a
10 Aug 21
Crinetics Pharmaceuticals Reports Second Quarter 2021 Financial Results
4:05pm
8-K
EX-99.2
y830n5bj1k
10 Aug 21
Crinetics Pharmaceuticals Reports Second Quarter 2021 Financial Results
4:05pm
8-K
EX-99.2
lv34wtq
29 Jul 21
Stock Purchase Agreement
4:15pm
8-K
n3m3kwojcaiws drlwt3
28 Jun 21
Other Events
7:30am
8-K
EX-99.1
wtf6r uv3mkev
6 May 21
Crinetics Pharmaceuticals Reports First Quarter 2021 Financial Results
4:01pm
8-K
EX-1.1
mmfndg
8 Apr 21
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:09pm
424B5
ozoi 7vwn
8 Apr 21
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
4cl nr83p
30 Mar 21
Crinetics Pharmaceuticals Announces 2021 Clinical Plans and Reports Fourth Quarter and Full Year 2020 Financial Results
5:05pm
8-K
dqlk3nvzzw0 o088
4 Feb 21
Other Events
7:00am
8-K
m2o06umd6druskyia6k8
3 Feb 21
Other Events
7:00am
8-K
EX-99.1
1tvj4x7cowq1
6 Nov 20
Crinetics Pharmaceuticals Reports Third Quarter 2020 Financial Results
8:30am
8-K
j15c11 z0
26 Oct 20
Regulation FD Disclosure
6:55am
8-K
EX-99.1
d0bj0rhc5dk6atkuc s7
26 Oct 20
Regulation FD Disclosure
6:55am
8-K
EX-99.1
4jzsvn3kw0wqn
3 Sep 20
Crinetics Pharmaceuticals Appoints Rare Disease Executive, Camille L. Bedrosian, M.D., to Board of Directors
7:35am